Biomarker
GlycanAge
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
What it is
GlycanAge estimates biological age from the relative abundance of sugar chains (glycans) attached to circulating immunoglobulin G (IgG). The specific pattern of IgG glycosylation — particularly the ratio of galactosylated and sialylated to agalactosylated forms — reflects the balance between pro- and anti-inflammatory immune signalling.
Why it matters
IgG glycan changes track chronic inflammation, which is one of the most consistent age-related signatures (Chronic inflammation). The signal is relatively stable over weeks to months and responds to lifestyle changes, hormone-replacement therapy, and disease.
Strengths and limitations
- Strengths: biologically grounded in inflammation; responsive to interventions on the timescale of months; relatively reproducible.
- Limitations: correlates with but is not redundant with epigenetic clocks; single time-point interpretation should be treated with the same caution as any biological-age test.
Practical use
Sold as a direct-to-consumer test in several markets. Like all biological- age tests, it is most informative as a trend over time and in the context of other clinical biomarkers, not as a single number.
Related entries
See also: Chronic inflammation, hsCRP, Epigenetic clocks.
References
- Krištić, J. et al. Glycans are a novel biomarker of chronological and biological ages. J. Gerontol. A Biol. Sci. Med. Sci. 69, 779–789 (2014).